Neuroone Medical Technologies (NMTC) Raw Materials (2023)

Neuroone Medical Technologies (NMTC) reported Raw Materials of $1.0 million for Q4 2023, down 13.21% sequentially from $1.2 million in Q3 2023.

Neuroone Medical Technologies (NMTC) Raw Materials (2023) Analysis & Trends

Neuroone Medical Technologies has disclosed Raw Materials across 1 years of filings, most recently posting $1.0 million for Q4 2023.

  • Quarterly Raw Materials changed N/A year-over-year to $1.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.0 million (changed N/A YoY) and the FY2023 annual result came in at $1.2 million, changed N/A from the prior year.
  • Raw Materials declined to $1.0 million in Q4 2023, from $1.2 million in the prior quarter.
  • Across five years, Raw Materials topped out at $1.2 million in Q3 2023 and bottomed at $1.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Neuroone Medical Technologies 26.73 Mn 23.93 Mn 990,264.00

Historic Data

Download Data
DateValue
Dec 31, 2023 1.04 Mn
Sep 30, 2023 1.20 Mn